It is with great pride that we welcome, within the Group, the Dutch company Immune-IT, a specialist in IT services, testing and digital transformation. This new acquisition allows us to establish ourselves in 2 new countries: the Netherlands and Belgium.
Once again, this transaction is part of an active strategy to develop our international footprint and consolidate our sector positions. This merger allows us to strengthen our offer in a key area in Western Europe.
We now have more than 100 employees in the Netherlands, spread over offices in Amsterdam, Rotterdam and Bois le Duc, and 30 employees in Belgium in Aalst, for a turnover of 13 million euros.
“We are very happy to be part of Astek’s ambitious growth plan and to be its flagship in the Netherlands and Belgium. We are convinced that the significant commercial synergies between France, the Netherlands and Belgium, combined with our skills, will allow us to offer global support to our customers and thus accelerate our development”, said Marc Boesveldt CEO of Immune-IT.
Julien Gavaldon, Group’s Chairman of the Board, declares:
“The merger with Immune-IT is a key step in the international development of the Astek Group, allowing it to establish a position both in Belgium and in the Netherlands. Supporting their numerous clients for more than 15 years, Immune-IT’s teams have recognized expertise in IT and digital services. We are delighted to welcome them within the Group.”
“The merger with Immune-IT is a key step in the international development of the Astek Group, allowing it to establish a position both in Belgium and in the Netherlands. Supporting their numerous clients for more than 15 years, Immune-IT’s teams have recognized expertise in IT and digital services. We are delighted to welcome them within the Group.”
The Astek Group plans to continue its policy of targeted acquisitions, which, combined with double-digit organic growth (especially internationally), will enable its turnover to reach 500 million euros in 2024.
.
.